StockNow
Calendar
Log in
U.S. Markets

Edwards Lifesciences (EW) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.74), Revenue 1.72bln (exp. 1.68bln)

ORIGINAL · NewsquawkEdwards Lifesciences (EW) Q3 2026 (USD): Adj. EPS 0.80 (exp. 0.74), Revenue 1.72bln (exp. 1.68bln)Read originalHide original

Sees Q4 Adj. EPS USD 0.61-0.69 (exp. 0.71) Sees Q4 rev. 1.67bln-1.75bln (exp. 1.70bln)

StockNow breaking-news AI analysis

Q3 adjusted EPS and revenue were above stated expectations. Q4 adjusted EPS and revenue ranges straddle or sit below their respective stated expectations.

News detail

Sees Q4 Adj. EPS USD 0.61-0.69 (exp. 0.71) Sees Q4 rev. 1.67bln-1.75bln (exp. 1.70bln)

1 stocks
EWEdwards Lifesciences Corp$101.63Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

US Senate Democratic Leader Schumer says they will end the war, some Republicans have joined them; Americans don't know why a war was launched against Iran and it should end

Geopolitics

US President Trump has been asking advisers whether Defense Secretary Hegseth should stay in his job following Republicans’ heavy losses on Tuesday night, CBS News reports citing sources

U.S. Markets

Intel (INTC) CEO bought USD 9.71mln of stock at USD 64.73/shr amid the sell-off

INTC